Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
Active, not recruitingOBSERVATIONAL
Enrollment
70
Participants
Timeline
Start Date
September 1, 2024
Primary Completion Date
September 1, 2025
Study Completion Date
September 1, 2025
Conditions
SarcomaSarcoma, BoneEwing SarcomaOsteosarcoma
Trial Locations (1)
100044
Peking University People's Hospital, Beijing
All Listed Sponsors
lead
Peking University People's Hospital
OTHER
NCT06850506 - Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment | Biotech Hunter | Biotech Hunter